News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stentix won the 2025 Y-Prize competition after presenting their business plan for a bile duct stent that can be adjusted noninvasively to help patients maintain bile flow without further surgical inte
PCI was featured as the lead story in the January 17th issue of Penn Today in recognition of its 10-year anniversary.
Eight teams completed the program, and 26 individuals received valuable training in entrepreneurship.
Eleven fellows were admitted to the 2023/2024 cohort out of a large application pool.
In the interview, Dr. Swartley talks about how he leads and supports innovation initiatives across Penn and his career in technology transfer.
Michael Kahana was recently featured in the New York Post for his cutting-edge research in memory recall.
Dr. Yang’s focus is developing low-cost and recycled carbonated materials that are safe for, and tolerant of, the marine environment.
This partnership focuses on transforming Dr. Weigelt's community program, "Bridges to Wealth," into a broader initiative called "Champions for Financial Legacy."
A group of researchers at Penn Engineering led by Michael Mitchell, PhD, Associate Professor in Bioengineering, have developed a method to direct lipid nanoparticles (LNPs) to target specific tissues.
Franklin Biolabs, a Penn spinout founded by James Wilson, MD, PhD, Rose H. Weiss Professor in Penn Medicine, has named Vatsala Naageshwaran as its first chief executive officer.